Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Which Indices Are Most Followed By Investors highlights the benchmarks that attract the most attention from market participants and why their popularity matters.
27,878 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Air-taxi darlings Joby, Archer, and EHang have fallen sharply in 2026 as cert timelines and cash burn loom large. Inv...
Dive into veeva (veev) 2026 earnings with a close look at Q4 results, guidance, and what the numbers mean for investo...
As geopolitical tensions rise, investors reassess defense exposure. This report examines the weapons that changed war...
Dianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
SpaceX aims for the largest IPO in history, targeting a $135-per-share price and up to $75 billion in proceeds. Durin...
Memory prices and AI data demands have put Micron and Sandisk in the spotlight. This piece breaks down what’s driving...
Amazon executed a $25 billion debt sale that drew heavy demand and extended its growth funding runway. Here are three...
Investors often ask where will stock years? BYD’s five-year path holds both promise and risk. This guide breaks down ...
Greg Abel, two months into his role as Berkshire Hathaway CEO, commits to using his after-tax salary to buy Berkshire...
Decades of secrecy around cutting-edge defense programs are giving way to public scrutiny and market reassessment. In...
Six ETFs now cover the entire grid-resilience thesis, from hardware and software to infrastructure and energy metals,...